Description: RegeneRx is a publicly traded, clinical-stage, biopharmaceutical company engaged in the design, research and development of novel peptides targeted at diseases with unmet medical needs. RegeneRxâs mission is to research and develop novel pharmaceuticals that protect and repair tissue and organ damage caused by disease, trauma or other pathology.
Home Page: www.regenerx.com
15245 Shady Grove Road
Rockville,
MD
20850
United States
Phone:
301 208 9191
Officers
| Name | Title |
|---|---|
| Dr. Allan L. Goldstein Ph.D. | Founder, Chairman, Chief Scientific Officer & Chairman of Scientific Advisor Board |
| Mr. J. J. Finkelstein | Pres, CEO & Director |
| Dr. Nabila A. Turjman Ph.D. | Exec. Director of Regulatory Affairs |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 261.8127 |
| IPO Date: | 1986-12-23 |
| Fiscal Year End: | December |
| Full Time Employees: | 3 |